---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-000259"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:55:49.409748+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics secures ~$3.3M via warrant exercise inducement, issues new warrants

## Summary
- Holders exercise 2,221,523 existing warrants at $1.35 per share; new warrants issued for same number at $1.50.
- Gross proceeds ~$3.3M; closing expected Jan 30, 2025; net proceeds for general corporate purposes.
- Placement agent H.C. Wainwright receives 7.0% cash fee and 1.0% management fee; also receives placement agent warrants.
- New warrants exercisable for 24 months from registration statement effective date; cashless exercise feature.
- Company agrees not to issue shares or file registration statements until March 18, 2025; no Variable Rate Transactions for one year.

## SEC filing metadata
- accession: 0001178913-25-000259
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325000259/0001178913-25-000259-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325000259/zk2532621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-000259
- JSON: https://secwatch.observer/filing/0001178913-25-000259.json
- Plain text: https://secwatch.observer/filing/0001178913-25-000259.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.